Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome02:18

The Proteasome

10.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K
The Proteasome01:13

The Proteasome

1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

4.5K
4.5K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.8K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.1K
3.1K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

14.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Peptidomics profiling identifies endogenous peptides associated with meningeal afferent activation in a chronic migraine mouse model.

The journal of headache and pain·2026
Same author

Surface attachment of fucoidan through electrostatic interaction alleviates chitosan/chitosan oligosaccharide-induced reduction in protein digestion.

Journal of the science of food and agriculture·2026
Same author

FoldDoF: Utilizing the Primary Degrees of Freedom of Protein Backbone for Geometric Modeling and Generation.

Journal of chemical information and modeling·2026
Same author

Thulium fiber laser versus holmium:YAG laser for ureteroscopic lithotripsy: a single-center retrospective cohort study.

Frontiers in surgery·2026
Same author

Bioactive Magnesium Silicate Activating Myocardial Energy Metabolism For Infarcted Myocardium Repair.

Exploration (Beijing, China)·2026

Related Experiment Video

Updated: Jan 22, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.0K

Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation.

Chen Song1,2, Qi Liu1,2, Tingjian Wang1,2

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Angewandte Chemie (International Ed. in English)
|January 20, 2026
PubMed
Summary

Researchers developed Proteasome Cap Targeting Chimeras (CAP-TACs) to directly recruit disease proteins to the proteasome. This novel strategy achieves targeted protein degradation without ubiquitination, offering a simpler therapeutic approach.

Keywords:
CAP‐TACProteasome cap region protein induced degradationRPN13 induced degradationSmall molecule recruiter to proteosomeUbiquitination independent degradation

More Related Videos

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K
Detection of Protein Ubiquitination
09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

43.6K

Related Experiment Videos

Last Updated: Jan 22, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.0K
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K
Detection of Protein Ubiquitination
09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

43.6K

Area of Science:

  • Molecular Biology
  • Drug Discovery
  • Proteasome Biology

Background:

  • Targeted protein degradation is a key therapeutic strategy.
  • Current methods use E3 ligases and ubiquitination, which are complex.
  • Direct proteasome recruitment offers a simpler alternative.

Purpose of the Study:

  • To evaluate direct recruitment of non-ubiquitinated proteins to the proteasome.
  • To develop small molecules for this purpose.
  • To demonstrate ubiquitination-independent degradation of disease proteins.

Main Methods:

  • Utilized a tag strategy to identify proteasome binding sites.
  • Developed Proteasome Cap Targeting Chimeras (CAP-TACs).
  • Tested CAP-TACs on various disease-associated proteins (BRD4, PRMT5, FKBP12).

Main Results:

  • RPN13 and RPN1 proteins can recruit non-ubiquitinated proteins to the proteasome.
  • CAP-TACs successfully recruited distinct proteins to the 19S proteasome cap.
  • Induced ubiquitination-independent, proteasome-dependent degradation of target proteins.

Conclusions:

  • Direct proteasome recruitment is feasible for targeted protein degradation.
  • CAP-TACs offer a novel, simplified approach to protein degradation therapy.
  • This broadens the scope of targeted protein degradation strategies.